PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Chart, page-3199

  1. 1,716 Posts.
    lightbulb Created with Sketch. 1865
    Nothing really. It's just another cross trade like the others we've seen go through recently. My best guess is that Bell Potter, having inherited the shortfall from the entitlement offer, is selling the shares on to insto's who participated in the placement.

    Bell Potter wouldn't have necessarily wanted these shares, and might feel over-exposed holding them. I don't think it reflects one way or the other on 008 for example. It would probably always have been part of the plan to move on much of the excess that fell to them if/when the entitlement offer was undersubscribed.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.